Company Filing History:
3 out of 3 
2 out of 20 
1 out of 76 Years Active: 2002-2009
Title: Innovator Spotlight: Lorenz Poellinger
Introduction
Lorenz Poellinger, a distinguished inventor based in Stockholm, Sweden, has made significant contributions to the field of biotechnology. With six patents to his name, his innovative work focuses on medical applications, particularly in the area of gene modulation and cancer treatment.
Latest Patents
Among his latest patented inventions is a method for identifying modulators of the dioxin/aryl hydrocarbon receptor (AHR). This method enables the identification of agents capable of binding to the AHR, which can suppress or inhibit gene expression associated with certain diseases. The applications of these agents are particularly relevant in pharmaceutical compositions aimed at the prevention and treatment of gastrointestinal diseases, including gastrointestinal and gastric cancer. Additionally, he holds a patent on the regulation of hypoxia-inducible gene expression with antisense inhibitory PAS domain protein. This pharmaceutical composition is designed to increase angiogenesis and stimulate HIF-1α function to treat hypoxia-related conditions.
Career Highlights
Lorenz Poellinger has been associated with reputable companies such as Angiogenetics Sweden AB and Index Pharmaceuticals AB, where he has leveraged his expertise to advance research in biomedicine. His career reflects a robust commitment to innovation and scientific discovery, underscoring the importance of interdisciplinary collaboration in his field.
Collaborations
Throughout his career, Poellinger has collaborated with notable colleagues including Anders Berkenstam and Patrik Andersson. These collaborations have played a crucial role in enhancing the scope and impact of his research endeavors.
Conclusion
Lorenz Poellinger exemplifies the innovative spirit of inventors pushing the boundaries of science and technology. His pioneering patents not only contribute to the scientific community but also hold promise for improving patient outcomes in medical treatments. As he continues to explore the complexities of gene modulation, his work will undoubtedly pave the way for future advancements in biotechnology.